|
|
|
|
 |
|
|
|
【孩童二價疫苗獲批】能更有效抗BA.4和BA.5
(2022/12/9)
【明報專訊】聯邦衛生部今日公布批准輝瑞生產、專供5至11歲孩童使用的二價疫苗。
輝瑞生產的這一款疫苗，能更有效對抗Omicron變種病毒衍生的亞變種病毒BA.4和BA.5。
|
|
|
|
|
|
|
|
| A D V E R T I S E M E N T |
|
| |
| |
| |
|
|
| |
| A D V E R T I S E M E N T |
|
| |
| |
| |
|
|
|
| |
|
|
|
| [] [] [] [] [] [] |
|
|
|
| MING PAO DAILY NEWS |
| A wholly owned subsidary of Ming Pao Enterprise Corporation Ltd. |
|
|
1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1
Tel.: (416) 321-0088 Fax: (416) 321-9663 Advertising Hotline Tel: (416) 673-8250
|
|
|
|
